Big data study could speed up breast cancer drug approvals
NCT ID NCT03676257
First seen Dec 29, 2025 · Last updated May 14, 2026 · Updated 16 times
Summary
This study looked at information from about 20,000 women with metastatic breast cancer to see if other measures of treatment success could replace the standard 'overall survival' endpoint. The goal was to find faster ways to tell if a treatment is working, which could help bring effective drugs to patients sooner. Researchers used real-world data from medical records and databases rather than running a new clinical trial.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for METASTATIC BREAST CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Insitut Bergonié
Bordeaux, 33076, France
Conditions
Explore the condition pages connected to this study.